Balancing Aggressive Treatment and Quality of Life in Prostate Cancer Therapy

3 Views
Published
In the second part of this roundtable, a panel of urologic oncologists and prostate cancer experts discuss the critical factors for identifying and managing progression in prostate cancer. The conversation covers both localized, low-volume disease and metastatic and castration-resistant stages. Key topics include the importance of risk stratification tools like PSA velocity and doubling time, the evolving role of precision medicine with ctDNA and germline testing, and balancing aggressive treatment with patient quality of life.
#prostatecancer #urology #cancerresearch #cancer
Category
Urology
Be the first to comment